NDA 11073, held by Medpointe Pharm Hlc. Niacin.
As of Nov 13, 2026, NDA 11073 (Wampocap), held by Medpointe Pharm Hlc, was first approved by FDA on Jul 24, 1957, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 24, 1957 | Original applicationNew combination · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Wampocap500MG · capsule;oral | Niacin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
